Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
53.6%
% of PBE's 28 holdings also in BBP
24.6%
% of BBP's 65 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 4.6% | 2.1% | 2.1% |
|
ACADIA PHARMACEUTICALS INC | 2.9% | 1.9% | 1.9% |
|
BIOCRYST PHARMACEUTICALS INC | 2.5% | 1.8% | 1.8% |
|
TG THERAPEUTICS INC | 4.2% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 5.4% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to BBP
|
ILLUMINA INC | 5.6% |
|
XENCOR INC | 4.1% |
|
NATERA INC | 3.9% |
|
VERACYTE INC | 3.7% |
|
UNITED THERAPEUTICS CORP | 3.7% |
|
VERICEL CORPORATION | 3.0% |
|
CATALYST PHARMACEUTICAL PART | 3.0% |
|
BIO-TECHNE CORPORATION | 2.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.9% |
|
REPLIGEN CORP | 2.9% |
PBE Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.9% |
|
IONIS PHARMACEUTICALS, INC. | -1.8% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | -1.8% |
|
ADMA BIOLOGICS, INC. | -1.8% |
|
GILEAD SCIENCES INC | -1.8% |
|
INSMED INC | -1.8% |